Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 17 of 17 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company 410 Medical Inc. | Activity: Research and Development | Company Description 410 Medical is developing technology for rapid infusion of fluids and blood products for hospital, transport and military healthcare providers, enabling clinicians to quickly and effectively resuscitate patients with shock and hypotension. | Location Research Triangle Park |
| |
Company Adhezion Biomedical LLC | Activity: Research and Development | Company Description Adhezion Biomedical develops and produces cyanoacrylate-based medical adhesive, wound care and microbial barrier products for connective tissue (human skin). The company's manufacturing and research facility is located in Hudson, N.C. | Location Hudson |
| |
Company Biocomposites Inc. | Activity: Sales and Operations | Company Description Biocomposites develops, manufactures and distributes calcium compound devices to regenerate and repair bone and soft tissue for use in musculoskeletal infections, trauma, spine and sports injuries. The Wilmington office is a sales office. | Location Wilmington |
| |
Company Chesson Laboratory Associates Inc. | Activity: Research and Development | Company Description Chesson Labs develops prescription and over-the-counter polymer-based medical products for wound care and skin and nail care products. | Location Durham |
| |
Company ConvaTec Inc. | Activity: Sales and Operations | Company Description ConvaTec develops and manufactures therapies for the management of chronic conditions, with a focus on advanced wound care, ostomy care, continence and critical care and infusion devices. The Triad site is the company's Global Quality Headquarters. | Location Greensboro |
| |
Company Entegrion Inc. | Activity: Research and Development | Company Description Entegrion offers a novel point of care in vitro diagnostic blood coagulation monitoring system for use in human and veterinary medicine. | Location Durham |
| |
Company Extrel Therapeutics Inc. | Activity: Research and Development | Company Description Extrel Therapeutics is developing medical devices to protect patients from post-operative infection, pain and inflammation. | Location Raleigh |
| |
Company GENIE Therapeutics | Activity: Research and Development | Company Description Genie Therapeutics develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs. | Location Winston-Salem |
| |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham |
| |
Company Insoma Bio Inc. | Activity: Research and Development | Company Description InSomaBio is developing recombinant, protein-based materials to solve problems in tissue engineering and regenerative medicine. | Location Durham |
| |
Company KeraNetics LLC | Activity: Research and Development | Company Description KeraNetics develops keratin-based biomaterials to be used for wound care and tissue regeneration. | Location Winston-Salem |
| |
Company Merakris Therapeutics Inc. | Activity: Research and Development | Company Description Merakris Therapeutics develops biotherapeutic technologies derived from stem cells that promote homeostasis in damaged tissue. | Location Research Triangle Park |
| |
Company Plakous Therapeutics Inc. | Activity: Research and Development | Company Description Plakous Therapeutics developed a cell-free placenta extract to prevent necrotizing enterocolitis in premature babies. The cytokines and growth factors purified in the product have anti-inflammatory, regenerative, and immunomodulatory properties analogous to mid-pregnancy amniotic fluid. | Location Winston-Salem |
| |
Company Praetego Inc. | Activity: Research and Development | Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. | Location Research Triangle Park |
| |
Company Revivo Therapeutics Inc. | Activity: Research and Development | Company Description Revivo Therapeutics is a clinical stage company developing therapies for cognitive dysfunction and neuroprotection. | Location Durham |
| |
Company Rilento Pharma LLC | Activity: Research and Development | Company Description Rilento Pharma is a preclinical stage drug delivery company developing non-addictive oral surgery pain management technologies that are synchronized with the biologic process of wound healing. | Location Raleigh |
| |
Company Tenax Therapeutics Inc. | Activity: Research and Development | Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. | Location Morrisville |